Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature

Introduction. Merkel cell carcinoma is a rare form of non-melanoma skin cancer of neuroendocrine origin. Optimal management of patients is controversial and the role of radiotherapy is unclear. Purpose. The purpose of this study was to review the efficacy of RT in the treatment of both local and d...

Full description

Bibliographic Details
Main Authors: Luluel Khan, Elizabeth A. Barnes
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Journal of Skin Cancer
Online Access:http://dx.doi.org/10.1155/2012/654981
id doaj-2ad3e19584304db393c81d90dcbed4d6
record_format Article
spelling doaj-2ad3e19584304db393c81d90dcbed4d62020-11-24T21:53:32ZengHindawi LimitedJournal of Skin Cancer2090-29052090-29132012-01-01201210.1155/2012/654981654981Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the LiteratureLuluel Khan0Elizabeth A. Barnes1Princess Margaret Hospital, 610 University Avenue, Toronto, ON, M5G 2M9, CanadaDepartment of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, CanadaIntroduction. Merkel cell carcinoma is a rare form of non-melanoma skin cancer of neuroendocrine origin. Optimal management of patients is controversial and the role of radiotherapy is unclear. Purpose. The purpose of this study was to review the efficacy of RT in the treatment of both local and distant metastatic disease from MCC. Methods. A literature search was conducted in MEDLINE (1946—January Week 1 2012) and Embase (1980–2012 Week 2). Articles of interest analyze the efficacy of radiotherapy for treatment of metastatic MCC and did not exclude case reports. Results. All articles except one focusing on the role of radiotherapy were of retrospective origin or case series. Significant limitations applied in all studies due to limited sample sizes and the retrospective nature of these studies. Radiotherapy improves locoregional control in the adjuvant setting, and many series suggest an improvement in overall survival. In cases where surgery is not possible, definitive radiotherapy may be an as-efficacious alternative. The radiosensitive nature of MCC coupled with existing reports suggests that treatment via current protocols for other primary tumors is adequate. Conclusion. Further studies should be conducted prospectively to clarify the true role of radiotherapy in metastatic MCC.http://dx.doi.org/10.1155/2012/654981
collection DOAJ
language English
format Article
sources DOAJ
author Luluel Khan
Elizabeth A. Barnes
spellingShingle Luluel Khan
Elizabeth A. Barnes
Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature
Journal of Skin Cancer
author_facet Luluel Khan
Elizabeth A. Barnes
author_sort Luluel Khan
title Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature
title_short Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature
title_full Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature
title_fullStr Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature
title_full_unstemmed Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature
title_sort radiotherapy for metastatic merkel cell carcinoma: a review of the literature
publisher Hindawi Limited
series Journal of Skin Cancer
issn 2090-2905
2090-2913
publishDate 2012-01-01
description Introduction. Merkel cell carcinoma is a rare form of non-melanoma skin cancer of neuroendocrine origin. Optimal management of patients is controversial and the role of radiotherapy is unclear. Purpose. The purpose of this study was to review the efficacy of RT in the treatment of both local and distant metastatic disease from MCC. Methods. A literature search was conducted in MEDLINE (1946—January Week 1 2012) and Embase (1980–2012 Week 2). Articles of interest analyze the efficacy of radiotherapy for treatment of metastatic MCC and did not exclude case reports. Results. All articles except one focusing on the role of radiotherapy were of retrospective origin or case series. Significant limitations applied in all studies due to limited sample sizes and the retrospective nature of these studies. Radiotherapy improves locoregional control in the adjuvant setting, and many series suggest an improvement in overall survival. In cases where surgery is not possible, definitive radiotherapy may be an as-efficacious alternative. The radiosensitive nature of MCC coupled with existing reports suggests that treatment via current protocols for other primary tumors is adequate. Conclusion. Further studies should be conducted prospectively to clarify the true role of radiotherapy in metastatic MCC.
url http://dx.doi.org/10.1155/2012/654981
work_keys_str_mv AT luluelkhan radiotherapyformetastaticmerkelcellcarcinomaareviewoftheliterature
AT elizabethabarnes radiotherapyformetastaticmerkelcellcarcinomaareviewoftheliterature
_version_ 1725871559060488192